COVID-19 Diagnostics. Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country. With Executive and Consultant Guides 2023-2027

List of Tables

OVERVIEW:

The pandemic may be ending but Covid-19 is here to stay.

This is still a dynamic market as multiple competitors are vying for the very lucrative future for respiratory diagnostics.

New variants and the situation in China have changed the pandemic outlook. And we have changed ours. Get the revised outlook based on the latest data. A new dynamic market is emerging for Covid-19 based diagnostics. Testing is moving into physicians' offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the Workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, technology, products and channels. They are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with our Market Guides and Situation Analysis.

All report data is available in Excel format on request. Make projections with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

B.Sc. (Chemistry) University of BC
M.B.A. (Finance and Policy) University of BC
Market Research Seminar - Burke Institute
Finance for Senior Executives - Harvard Business School

1. Market Guides

1.1. Strategic Situation Analysis
1.2. Guidance for Executives
1.3. COVID-19. Guidance for Management Consultants and Investment Advisors

2. Introduction and Market Definition

2.1. What are Pandemics?
2.2. The Role of Zoonosis
2.3. Market Definition
- 2.3.1. PCR
- 2.3.2. PCR Multiplex
- 2.3.3. SEQ
- 2.3.4. Antigen
- 2.3.5. Antibodies
- 2.3.6. Instruments
- 2.3.7. Reagents and Kits
- 2.3.8. Extract
- 2.3.9. Collect
- 2.3.10. Public
- 2.3.11. Hospital
- 2.3.12. Clinic
- 2.3.13. Workplace
- 2.3.14. DTC/OTC
- 2.3.15. Wastewater
2.4. Methodology
- 2.4.1. Sources
- 2.4.2. Authors
2.5. Historical Perspective on Pandemics
- 2.5.1. HIV/AIDS PANDEMIC 2005-2012
- 2.5.2. FLU PANDEMIC 1968
- 2.5.3. ASIAN FLU 1956-1958
- 2.5.4. SPANISH FLU 1918
- 2.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
- 2.5.6. FLU PANDEMIC 1889-1890
- 2.5.7. THE BLACK DEATH 1346-1353

3. The Pandemic Overview

3.1. What is a Virus?
- 3.1.1. Is a Virus Alive?
- 3.1.2. Viral Structure
- 3.1.3. The Viral Genome
- 3.1.4. Viral Mutation
3.2. The Coronavirus
- 3.2.1. Severe acute respiratory syndrome (SARS)
- 3.2.2. Middle East respiratory syndrome (MERS)
- 3.2.3. COVID-19. The SARS CoV 2 Virus.
  - 3.2.3.1. Signs and symptoms
  - 3.2.3.2. Transmission
  - 3.2.3.3. Diagnosis
  - 3.2.3.4. Prevention
  - 3.2.3.5. Management
  - 3.2.3.6. Prognosis
  - 3.2.3.7. A Note on Global Statistics Reporting
3.3. Pandemic Diagnostics
- 3.3.1. Risk Management-Spark and Spread
- 3.3.2. Dx Technology-Nucleic Acid Based
- 3.3.3. Dx Technology - Immunoassay
- 3.3.4. Time to Market and Preparedness Issues

4. Industry Structure

4.1. Players in a Dynamic Market
- 4.1.1. Academic Research Lab
- 4.1.2. Diagnostic Test Developer
- 4.1.3. Instrumentation Supplier
- 4.1.4. Chemical/Reagent Supplier
- 4.1.5. Pathology Supplier
- 4.1.6. Independent Clinical Laboratory
- 4.1.7. Public National/regional Laboratory
- 4.1.8. Hospital Laboratory
- 4.1.9. Physicians Office Lab (POLS)
- 4.1.10. Audit Body
- 4.1.11. Certification Body

5. Diagnostic Company Profiles

5.1. Abacus Diagnostica
5.2. Abbott Laboratories
5.3. Accel Diagnostics
5.4. Accelerate Diagnostics
5.5. Access Bio
5.6. ADT Biotech
5.7. Advanced Biological Laboratories
5.8. Agilent/Dako
5.9. Altona Diagnostics
5.10. Alveo Technologies
5.11. Anatolia Geneworks
5.12. Anitoa
5.13. Antelope Dx
5.14. Applied BioCode
5.15. Applied DNA Sciences
5.16. Assurance Scientific Laboratories
5.17. Aureum Diagnostics
5.18. Aurora Biomed
5.19. Aus Diagnostics
5.20. Autobio Diagnostics
5.21. Baebies
5.22. Beckman Coulter Diagnostics
5.23. Becton, Dickinson and Company
5.24. BGI Genomics Co. Ltd
5.25. BillionToOne
5.26. Binx Health
5.27. Biocartis
5.28. Biodesix Inc.
5.29. BioFire Diagnostics (bioMérieux)
5.30. Biolidics Ltd
5.31. bioMérieux Diagnostics
5.32. Bioneer Corporation
5.33. Bio-Rad Laboratories, Inc
5.34. Bio-Reference Laboratories
5.35. Bosch Healthcare Solutions GmbH
5.36. Celemics
5.37. Cepheid (Danaher)
5.38. Chembio
5.39. Co Diagnostics
5.40. Color Genomics
5.41. CTK Biotech
5.42. Cue Health
5.43. Curetis N.V. / Curetis GmbH
5.44. Detect
5.45. Diagenode Diagnostics
5.46. Diasorin S.p.A.
5.47. Domus Diagnostics
5.48. Element Biosciences
5.49. Ellume
5.50. Enzo Biochem
5.51. Everywell
5.52. Fluxergy
5.53. Fujirebio
5.54. Fulgent Genetics
5.55. Fusion Genomics.
5.56. Fyr Diagnostics
5.57. Genedrive
5.58. Genetic Signatures
5.59. GenMark Dx (Roche)
5.60. Genomadix
5.61. Gold Standard Diagnostics
5.62. Hibergene Diagnostics
5.63. Hologic
5.64. Illumina
5.65. Immunexpress
5.66. Inflammatix
5.67. Janssen Diagnostics
5.68. Karius
5.69. Laboratory Corporation of America
5.70. Letsgetchecked
5.71. Lexagene
5.72. LightDeck Diagnostics
5.73. Luminex (DiaSorin)
5.74. LumiraDx
5.75. Mammoth Biosciences
5.76. Mayo Clinic Laboratories
5.77. Mbio Diagnostics
5.78. Meridian Bioscience
5.79. Mesa Biotech (Thermo Fisher)
5.80. Mesa Laboratories, Inc.
5.81. MicroGem
5.82. Minute Molecular
5.83. Mobidiag (Hologic)
5.84. Molbio Diagnostics
5.85. NanoDx
5.86. Nanomix
5.87. Novacyt
5.88. OnsiteGene
5.89. OraSure Technologies
5.90. Oxford Nanopore Technologies
5.91. Perkin Elmer
5.92. Prenetics
5.93. Primerdesign (Novacyt)
5.94. Prominex
5.95. Qiagen
5.96. QuantuMDx
5.97. Quest Diagnostics
5.98. QuidelOrtho
5.99. Randox Toxicology
5.100. Salignostics
5.101. Scope Fluidics
5.102. SD Biosensor
5.103. Seegene
5.104. Sense Biodetection
5.105. Sherlock Biosciences
5.106. Siemens Healthineers
5.107. Singular Genomics
5.108. SomaLogic
5.109. Sona Nanotech
5.110. SpeeDx
5.111. Talis Biomedical
5.112. Thermo Fisher Scientific Inc.
5.113. Ultima Genomics
5.114. Vela Diagnostics
5.115. Veredus Laboratories
5.116. Vircell
5.117. Visby Medical
5.118. YD Diagnostics
5.119. Zhejiang Orient Gene Biotech

6. COVID-19 Diagnostics Recent Developments

6.1. Recent Developments-Importance and How to Use This Section
- 6.1.1. Importance of These Developments
- 6.1.2. How to Use This Section
6.2. CTK Biotech Gets EAU for At-Home COVID Antigen Test
6.3. FDA Grants EAU for Premier Medical At-Home COVID Assay
6.4. QuidelOrtho Seeks Home Testing Contract
6.5. Aptitude Medical Gets EUA for Over-the-Counter COVID Saliva MDx
6.6. Siemens Healthineers Gains CE Marks for Seasonal Viral Assays
6.7. NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
6.8. North American Dx Recalls Covid Rapid Antigen Tests
6.9. Domus Dx to Launch OC Diagnostics Test System
6.10. Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
6.11. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
6.12. At-Home COVID Test Coverage
6.13. LuminUltra Wins 500-Site CDC Wastewater Testing Contract
6.14. Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
6.15. Tests Called Back
6.16. Cepheid Obtains CE Mark for Expanded Combo COVID Test
6.17. CRISPR Tests for SARS-CoV-2 Using Saliva Samples
6.18. CVS Limits Purchases of Rapid COVID-19 Tests
6.19. Illumina, COVID-19 Surveillance Continue to Boost Business
6.20. LetsGetChecked Closes $150M Funding Round
6.21. Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
6.22. Abbott Sees Sharp Decline in COVID-19 Test Revenue
6.23. Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
6.24. NY Times Explores Multiplex Testing
6.25. Hologic Banking on MDx Acquisitions
6.26. Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022
6.27. DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
6.28. LumiraDx to Go Public Through SPAC
6.29. Eurofins Test Helps to ID Mutations
6.30. Roche Sees Growing Opportunities for Diagnostics
6.31. Roche to Acquire GenMark Diagnostics for $1.8B
6.32. Fulgent Genetics s to Use COVID-19 Testing Gains to Grow Clinical Sequencing
6.33. LexaGene Syndromic Panel Platform Lets Labs Customize Targets
6.34. FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests
6.35. At-Home Infectious Disease Test Developer Lucira Health Goes Public

7. The Global Market for COVID-19 Diagnostics

7.1. Global Market Overview by Country
- 7.1.1. Table-Global Market by Country
- 7.1.2. Chart - Global Market by Country
7.2. Global Market by Technology - Overview
- 7.2.1. Table-Global Market by Technology
- 7.2.2. Chart-Global Market by Technology-Base/Final Year Comparison
- 7.2.3. Chart-Global Market by Technology-Base Year
- 7.2.4. Chart-Global Market by Technology-End Year
- 7.2.5. Chart-Global Market by Technology-Share by Year
- 7.2.6. Chart-Global Market by Technology-Segments Growth
7.3. Global Market by Product - Overview
- 7.3.1. Table-Global Market by Product
- 7.3.2. Chart-Global Market by Product-Base/Final Year Comparison
- 7.3.3. Chart-Global Market by Product-Base Year
- 7.3.4. Chart-Global Market by Product-End Year
- 7.3.5. Chart-Global Market by Product-Share by Year
- 7.3.6. Chart-Global Market by Product-Segments Growth
7.4. Global Market by Channel - Overview
- 7.4.1. Table-Global Market by Channel
- 7.4.2. Chart-Global Market by Channel-Base/Final Year Comparison
- 7.4.3. Chart-Global Market by Channel-Base Year
- 7.4.4. Chart-Global Market by Channel-End Year
- 7.4.5. Chart-Global Market by Channel-Share by Year
- 7.4.6. Chart-Global Market by Channel-Segments Growth

8. Global COVID-19 Diagnostic Markets-By Technology

8.1. PCR
- 8.1.1. Table PCR-by Country
- 8.1.2. Chart - PCR Growth
8.2. PCR Multiplex
- 8.2.1. Table PCR Multiplex-by Country
- 8.2.2. Chart - PCR Multiplex Growth
8.3. Sequencing
- 8.3.1. Table Sequencing-by Country
- 8.3.2. Chart - Sequencing Growth
8.4. Antibody
- 8.4.1. Table Antibody-by Country
- 8.4.2. Chart - Antibody Growth
8.5. Antigen
- 8.5.1. Table Antigen-by Country
- 8.5.2. Chart-Antigen Growth

9. Global COVID-19 Diagnostic Markets-By Product

9.1. Instruments
- 9.1.1. Table Instruments-by Country
- 9.1.2. Chart - Instruments Growth
9.2. Reagents & Kits
- 9.2.1. Table Reagents & Kits-by Country
- 9.2.2. Chart-Reagents & Kits Growth
9.3. Extraction
- 9.3.1. Table Extraction-by Country
- 9.3.2. Chart - Extraction Growth
9.4. Collection
- 9.4.1. Table Collection-by Country
- 9.4.2. Chart - Collection Growth

10. Global COVID-19 Diagnostic Markets-By Channel

10.1. Public
- 10.1.1. Table Public-by Country
- 10.1.2. Chart - Public Growth
10.2. Hospital
- 10.2.1. Table Hospital-by Country
- 10.2.2. Chart - Hospital Growth
10.3. Clinic
- 10.3.1. Table Clinic-by Country
- 10.3.2. Chart - Clinic Growth
10.4. Workplace
- 10.4.1. Table Workplace-by Country
- 10.4.2. Chart - Workplace Growth
10.5. DTC/OTC
- 10.5.1. Table DTC/OTC-by Country
- 10.5.2. Chart-DTC/OTC Growth
10.6. Wastewater
- 10.6.1. Table Wastewater-by Country
- 10.6.2. Chart-Wastewater Growth

11. Appendix

11.1. U.S., Europe, Asia Approved COVID-19 Assays

Table of Tables

Table 1: Who List of Potential Pandemic Pathogens
Table 2: Characteristics of Coronavirus Pandemic Infections
Table 3: COVID-19 Symptoms
Table 4: Market Players by Type
Table 5: Global Market by Region
Table 7: Global Market by Technology
Table 8: Global Market by Product
Table 9: Global Market by Channel
Table 10: PCR by Country
Table 11: PCR Multiplex by Country
Table 12: Sequencing by Country
Table 13: Antibody by Country
Table 14: Antigen by Country
Table 15: Instruments by Country
Table 16: Reagents & Kits by Country
Table 17: Extraction by Country
Table 18: Collection by Country
Table 19: Public by Country
Table 20: Hospital by Country
Table 21: Clinic by Country
Table 22: Workplace by Country
Table 23: DTC/OTC by Country
Table 24: Wastewater by Country
Table 25: Approved Covid-19 Assays

Table of Figures

Figure 1: Global Distribution Pandemic Preparedness
Figure 2: Global Pandemic Pathogen Status
Figure 3: Estimated Economic Impact of Viral Pandemic by Region
Figure 4: Historical Pandemics Infographic
Figure 5: Antigenic Drift Creates a new Strain of Virus
Figure 6: Structure of Coronaviruses
Figure 7: The Road to Diagnostics
Figure 8: Global Market Share Chart
Figure 9: Base/Final Year Comparison Chart
Figure 10: Global Markets by Technology Base Year
Figure 11: Global Markets by Technology End Year
Figure 12: Global Markets by Technology Share by Year
Figure 13: Global Markets by Technology Segment Growth
Figure 14: Global Market by Product Base vs. Final
Figure 15: Global Market by Product Base Year
Figure 16: Global Market by Product End Year
Figure 17: Global Market by Product Share by Year
Figure 18: Global Market by Product Segments Growth
Figure 19: global Market by Channel - Base vs. Final
Figure 20: global Market by Channel - Base Year
Figure 21: global Market by Channel - End Year
Figure 22: global Market by Channel - Share by Year
Figure 23: global Market by Channel - Segments Growth
Figure 24: PCR Growth
Figure 25: PCR Multiplex Growth
Figure 26: Sequencing Growth
Figure 27: Antibody Growth
Figure 28: Antigen Growth
Figure 29: Instruments Growth
Figure 30: Reagents & Kits Growth
Figure 31: Extraction Growth
Figure 32: Collection Growth
Figure 33: Public Growth
Figure 34: Hospital Growth
Figure 35: Clinic Growth
Figure 36: Workplace Growth
Figure 37: DTC/OTC Growth
Figure 38: Wastewater Growth